secwatch.observer — SEC 8-K summary
======================================

Issuer:     OMNICELL, INC. (OMCL)
CIK:        0000926326
Form:       8-K
Filed at:   2026-07-01T12:27:47+00:00
Accession:  0001104659-26-079606
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omnicell appoints Nnamdi Njoku as President; Lipps remains CEO and Chairman
---------------------------------------------------------------------------

- Nnamdi Njoku appointed President of Omnicell effective July 1, 2026, while retaining COO role.
- Randall Lipps steps down as President but continues as CEO and Chairman of the Board; no compensation change.
- Njoku receives one-time RSU award of ~$500k vesting over three years; base salary unchanged at $661k, target bonus 100%.
- Njoku to lead growth strategy, launch of Titan XT automated dispensing system and OmniSphere platform.
- Njoku previously served as EVP and COO since Oct 2024; prior roles at Medtronic, Zimmer Biomet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926326/000110465926079606/0001104659-26-079606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926326/000110465926079606/tm2619353d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-079606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer